IT1313567B1 - USE OF N-ACETYL-CISTEIN FOR THE PREPARATION OF TOPICAL PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ALLERGIC PATHOLOGIES OF - Google Patents

USE OF N-ACETYL-CISTEIN FOR THE PREPARATION OF TOPICAL PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ALLERGIC PATHOLOGIES OF

Info

Publication number
IT1313567B1
IT1313567B1 IT1999MI001653A ITMI991653A IT1313567B1 IT 1313567 B1 IT1313567 B1 IT 1313567B1 IT 1999MI001653 A IT1999MI001653 A IT 1999MI001653A IT MI991653 A ITMI991653 A IT MI991653A IT 1313567 B1 IT1313567 B1 IT 1313567B1
Authority
IT
Italy
Prior art keywords
cistein
acetyl
preparation
treatment
pharmaceutical compositions
Prior art date
Application number
IT1999MI001653A
Other languages
Italian (it)
Inventor
Francesco Santangelo
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Priority to IT1999MI001653A priority Critical patent/IT1313567B1/en
Publication of ITMI991653A0 publication Critical patent/ITMI991653A0/en
Priority to AU69859/00A priority patent/AU6985900A/en
Priority to PCT/EP2000/007036 priority patent/WO2001007019A2/en
Publication of ITMI991653A1 publication Critical patent/ITMI991653A1/en
Application granted granted Critical
Publication of IT1313567B1 publication Critical patent/IT1313567B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
IT1999MI001653A 1999-07-27 1999-07-27 USE OF N-ACETYL-CISTEIN FOR THE PREPARATION OF TOPICAL PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ALLERGIC PATHOLOGIES OF IT1313567B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT1999MI001653A IT1313567B1 (en) 1999-07-27 1999-07-27 USE OF N-ACETYL-CISTEIN FOR THE PREPARATION OF TOPICAL PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ALLERGIC PATHOLOGIES OF
AU69859/00A AU6985900A (en) 1999-07-27 2000-07-21 Use of n-acetyl-cysteine in the manufacture of topical pharmaceutical compositions for the treatment of allergic pathologies of the respiratory tract
PCT/EP2000/007036 WO2001007019A2 (en) 1999-07-27 2000-07-21 Use of n-acetyl-cysteine in the treatment of allergic pathologies of the respiratory tract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI001653A IT1313567B1 (en) 1999-07-27 1999-07-27 USE OF N-ACETYL-CISTEIN FOR THE PREPARATION OF TOPICAL PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ALLERGIC PATHOLOGIES OF

Publications (3)

Publication Number Publication Date
ITMI991653A0 ITMI991653A0 (en) 1999-07-27
ITMI991653A1 ITMI991653A1 (en) 2001-01-27
IT1313567B1 true IT1313567B1 (en) 2002-09-09

Family

ID=11383417

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1999MI001653A IT1313567B1 (en) 1999-07-27 1999-07-27 USE OF N-ACETYL-CISTEIN FOR THE PREPARATION OF TOPICAL PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ALLERGIC PATHOLOGIES OF

Country Status (3)

Country Link
AU (1) AU6985900A (en)
IT (1) IT1313567B1 (en)
WO (1) WO2001007019A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT509045B1 (en) * 2010-01-29 2011-06-15 Planta Naturstoffe Vertriebsges M B H COMPOUNDS FOR THE TREATMENT OF ASTHMA BRONCHIALE
IT1405758B1 (en) * 2010-11-03 2014-01-24 Stewart Italia Srl NAC BASED PHARMACEUTICAL PREPARATION IN HYPERTONIC SOLUTION FOR THE TREATMENT OF RINOFARINGEAL AFFECTIONS
ITNA20110020A1 (en) * 2011-05-03 2012-11-04 Gruppo Farmaimpresa Srl NAC AND MSM PHARMACEUTICAL PREPARATION IN SOLUTION FOR THE TREATMENT OF RINOFARINGEAL AFFECTIONS

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA821525A (en) * 1969-08-26 L. Sheffner Aaron N-acetylcysteine containing composition
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
EP0954318A1 (en) * 1996-06-04 1999-11-10 The Procter & Gamble Company A nasal spray containing an intranasal steroid and an antihistamine
WO1998047497A2 (en) * 1997-04-23 1998-10-29 Fleming & Company, Pharmaceuticals Methods and compositions for the prevention and treatment of immunological disorders, inflammatory diseases and infections
AU6878098A (en) * 1997-04-30 1998-11-24 Warner-Lambert Company Topical nasal antiinflammatory compositions
FR2788436A1 (en) * 1999-01-14 2000-07-21 Pf Medicament Composition useful for treating allergic rhinitis contains phenothiazine derivative in aqueous stabilized with sulfur-containing amino acid derivative

Also Published As

Publication number Publication date
ITMI991653A0 (en) 1999-07-27
WO2001007019A2 (en) 2001-02-01
WO2001007019A3 (en) 2001-09-27
AU6985900A (en) 2001-02-13
ITMI991653A1 (en) 2001-01-27

Similar Documents

Publication Publication Date Title
ITMI20020756A1 (en) TOPICAL PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DERMATITIS
DK1453517T3 (en) Pharmaceutical formulations with platinum derivative
EE05378B1 (en) Use of soluble ÁCTLA4AFusion molecule for the preparation of a pharmaceutical composition
ITMI20001732A0 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF MUCOSITIS AND STOMATITIS
EE04418B1 (en) Pharmaceutical preparation of moxifloxacin
AR027906A1 (en) USE OF OPHTHALM AGENT
HUP0303751A3 (en) Use of n-phenyl-2-pyrimidineamine derivatives for preparation of pharmaceutical compositions suitable for treating mast cell-based diseases like allergic disorders
ITMI20011057A0 (en) PREPARATION AND USE OF CYCLIC AND BRANCHED PEPTIDES AND THEIR DERIVATIVES MARKED AS THERAPEUTIC AGENTS AGONISTS OR ANTAGONISTS OF CHOLECYSTOCHI
IT1313567B1 (en) USE OF N-ACETYL-CISTEIN FOR THE PREPARATION OF TOPICAL PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ALLERGIC PATHOLOGIES OF
EE200300468A (en) Stable pharmaceutical composition of pravastatin
ITMI20000050A0 (en) PROCEDURE FOR THE PREPARATION OF 5-CARBOXYPHTALIDE
AR025867A1 (en) PHARMACEUTICAL PORTASDORA FORMULATION
EE200300436A (en) Imidazolidine derivatives, their preparation and use as anti-inflammatory agents and pharmaceutical preparations containing them
PT1385512E (en) USE OF PYRIDINDOLONE DERIVATIVES FOR THE PREPARATION OF ANTICANCERIGENE MEDICINES
IT1317836B1 (en) USE OF TIAMFENICOLO FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE TREATMENT OF STAPHYLOCOCCI INFECTIONS
ITRM990728A0 (en) COMPOSITION TO STIMULATE THE INTERRUPTION OF DORMANCY OF FRUIT-BEARING BUDS AND ITS USE.
ITMI20001053A0 (en) OPTICALLY ACTIVE 2-AMINOTETRALIN DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND THERAPEUTIC USE OF THE CORRESPONDING COMPOSITIONS
IT1290003B1 (en) USE OF PIVAGABINA TO PREPARE PHARMACEUTICAL COMPOSITIONS
ITMI20001282A0 (en) USE OF N-ACETYLCYSTEINE FOR THE PREPARATION OF ORAL PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ASTHMA
ITMI20000776A0 (en) USE OF THIAMPHENICOL AND ITS DERIVATIVES FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE TREATMENT OF CHLAMYDIA INFECTIONS
ITMI20011310A0 (en) PHARMACEUTICAL COMPOSITIONS FOR THE THERAPY OF ARTHEROSCLEROTIC-THROMBOTIC PATHOLOGICAL CONDITIONS
ITMI20011456A0 (en) ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION FOR TOPICAL USE
AU2001289719A1 (en) Use of anellated dihydropyridines for the preparation of pharmaceutical compositions for the treatment of chronic pain
ITBO20020022A1 (en) PHARMACEUTICAL COMPOSITIONS FOR SKIN CARE AND THEIR USE
ITMI20020755A1 (en) TOPICAL PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SCABBIA